Overview Fundamentals Financials Technicals Corporate Action Shareholding Pattern Peer Comparison News Stock Analysis About Company FAQs

Suven Life Sciences Ltd Share Price

Miscellaneous - Medium / Small

NSE: SUVEN Small Cap ISIN: INE495B01038
As on 22 January 2025 at 18:24 IST
As on 22 January 2025 at 18:24 IST
125.50
-4.77
(-3.66%)
Over 1 Month
-1.14%
Over 6 Months
-1.11%
Over 1 Year
19.62%
Over 3 Years
53.44%

Suven Life Sciences Ltd Summary

Close ₹ 125.50
Open ₹ 131.31
High ₹ 132.18
Low ₹ 124.10
Volume 3,99,826
Net Turnover (in ₹) ₹ 5,63,57,269.25
52Wk High ₹ 169.30
52Wk Low ₹ 82.95
52Wk High / Low
82.95
169.30

Suven Life Sciences Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 2,840.85
EPS (TTM) -
Book Value (BV) 37.93
Div. Yield -
P/E (TTM) -106.80
Price/Book Value 3.44
Delivery % 56.01 %
Face Value 1

Key Ratios

PE Ratio -
PB Ratio 2.57
EV to Sales 172.92
PEG Ratio -
ROA -0.95
ROE -2.36
Debt-Equity -
Net Profit Margin -171.26
Operating Profit Margin -122.16

Suven Life Sciences Ltd Financials

Profit and Loss

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Total Revenue32.8221.9913.4521.2328.45
Total Expenses146.36146.26139.1698.71134.85
Profit Before Tax-106.08-118.27-122-77.47-106.40
Profit After Tax-105.08-118.27-122-72.15-94.22
Operating Profit after Depreciation-113.38-123.98-125.18-76.66-105.91

Balance Sheet

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Fixed Assets28.2137.2137.5620.9624.69
Total Non Current Assets28.23137.3241.4425.74115.95
Total Current Assets256.67251.5966.59102.6865.99
TOTAL ASSETS284.90388.91108.03128.42181.93
Total Shareholder's Fund270.04375.3296.15108.01143.35

Cash Flow

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash from Operating Activities-115.47-115.98-127.54-96.02-134.57
Net Cash used in Investing Activities94.44-247.81-22.2355.84146.22
Net Cash used in Financing Activities-1.05395.54145.6934.862.81

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Total Revenue32.8221.9913.4521.2328.45
Total Expenses49.2948.1253.4149.1954.39
Profit Before Tax-9.01-20.13-36.25-27.95-25.94
Profit After Tax-8.01-20.13-36.25-22.63-13.75
Operating Profit after Depreciation-16.31-25.84-39.43-27.14-25.45

Balance Sheet

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Fixed Assets28.2137.2137.5620.9624.69
Total Non Current Assets605.34619.18422.13320.76357.76
Total Current Assets246.14241.2664.2294.6252
TOTAL ASSETS851.48860.44486.35415.39409.76
Total Shareholder's Fund845.38853.44475.98401.65387.67

Cash Flow

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash from Operating Activities-20.56-22.92-36.62-36.68-45.15
Net Cash used in Investing Activities-0.68-348.82-107.462.4142.03
Net Cash used in Financing Activities-1.05395.54145.6934.863.81

Particulars (in ₹ Cr.) 2024-09 2024-06 2024-03 2023-12 2023-09
Total Revenue2.571.012.392.453.06
Total Expenses54.7831.5432.6748.6526.57
Profit Before Tax-49.65-28.03-27.54-41.77-12.68
Profit After Tax-49.64-28.04-26.54-41.76-12.68
Operating Profit after Depreciation-48.17-26.52-26-40.13-18.37

Particulars (in ₹ Cr.) 2024-09 2024-06 2024-03 2023-12 2023-09
Total Revenue2.571.012.392.453.06
Total Expenses16.2011.099.2511.6511.13
Profit Before Tax-11.08-7.66-4.12-4.772.76
Profit After Tax-11.07-7.67-3.12-4.772.76
Operating Profit after Depreciation-9.60-6.15-2.58-3.13-2.93

Suven Life Sciences Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3
S1 127.47
S2 124.67
S3 119.64
Pivot 132.50
R1 135.30
R2 140.33
R3 143.13

Moving Average

20 SMA 130.94
50 SMA 132.47
100 SMA 135.81
200 SMA 126.12

Suven Life Sciences Ltd Corporate Actions

No available data

Suven Life Sciences Ltd Peer Comparison

Company Price Market Cap (in ₹ Cr)
Suven Life Sciences Ltd ₹130.30 ₹2,841.50
Max Healthcare Institute Ltd ₹1,078.10 ₹1,04,805.56
Apollo Hospitals Enterprise Ltd ₹6,918.65 ₹99,479.57
Fortis Healthcare Ltd ₹639.80 ₹48,302.22
Syngene International Ltd ₹832.10 ₹33,495.10
Global Health Ltd ₹1,055.75 ₹28,356.11

Suven Life Sciences Ltd News

Suven Life Sciences to convene board meeting

On 24 January 2025

17 Jan 2025, 10:26 am

Suven Life spurts on initiating Phase-1 of clinical trial in US

Suven Life Sciences surged 9.51% to Rs 138.70 after the firm dosed first subjects in a Phase-1 clinical trial of SUVN-I6107 being conducted in USA under FDA acceptance of investigational new drug (IND).

08 Jan 2025, 02:29 pm

Suven Life Sciences announces board meeting date

On 29 October 2024

21 Oct 2024, 05:47 pm

Suven Life hits lower circuit as Q1 net loss widens to Rs 28 cr

Suven Life Sciences was locked in lower circuit of 5% at Rs 135.25 after its consolidated net loss stood at Rs 28.04 crore in Q1 FY25 as compared with a net loss of Rs 24.09 crore in Q1 FY24.

05 Aug 2024, 02:00 pm

Suven Life Sciences announces board meeting date

On 5 August 2024

30 Jul 2024, 10:24 am

Suven Life Sciences Ltd Stock Analysis

  1. Annual revenue for Suven Life Sciences Ltd increased by 49.28% to ₹32.82 crore in FY 2024 from ₹21.99 crore in FY 2023.
  2. Annual Net Profit for Suven Life Sciences Ltd decreased by 60.21% to ₹-8.01 crore in FY 2024 from ₹-20.13 crore in FY 2023.
  3. Promoter Shareholding in Suven Life Sciences Ltd remains unchanged by 0.00% in the most recent quarter, from 70.27% in September 2024 to 70.27% in December 2024.
  4. Suven Life Sciences Ltd delivered a 1-year return of 19.62% compared to the Nifty 50, which provided a return of 8.41% as of the last trading session.
  5. Suven Life Sciences Ltd share price moved down by 3.66% from its previous close of INR ₹130.27. The latest Suven Life Sciences Ltd share price is INR ₹125.50.
  6. Suven Life Sciences Ltd share price today has been at a low of 124.10 and a high of 132.18. Over the past 52 weeks, the Suven Life Sciences Ltd share price has seen a low of 82.95 and a high of 169.30.

FAQ’s

What is the share price of Suven Life Sciences Ltd today?

Suven Life Sciences Ltd share price as on 22 Jan 2025 is ₹ 125.5

What is the Market Cap of Suven Life Sciences Ltd?

The market cap of Suven Life Sciences Ltd stock is ₹2,840.85 Cr.

What is the PE Ratio of Suven Life Sciences Ltd?

The Price to Earnings (P/E) Ratio of Suven Life Sciences Ltd is -

What is the PB Ratio of Suven Life Sciences Ltd?

The Price to Book (P/B) Ratio of Suven Life Sciences Ltd is 2.57

What is the 52 week high of Suven Life Sciences Ltd Share Price?

The 52 week high of Suven Life Sciences Ltd share price stands at ₹169.30

What is the 52 week low of Suven Life Sciences Ltd Share Price?

The 52 week low of Suven Life Sciences Ltd share price stands at ₹82.95

Get started with us today and
start building your wealth journey